Top 10 Companies in the Romania Colorectal Cancer Market | Competitive Landscape 2026

Romania Colorectal Cancer Market Overview

According to 6Wresearch, the Romania Colorectal Cancer market is expected to grow steadily, as the prevalence of gastrointestinal cancers increases, along with the implementation of nationwide screening programs. Moreover, the need to develop effective treatments and the increasing focus on oncological health, are driving the market growth further.

Colorectal cancer is a malignancy, affecting the colon or rectum, that greatly impacts the quality of life and mortality rates in the country. Efforts to innovate and develop special treatments for such disorders, including targeted therapies and immunotherapy, is also boosting the market. Also, companies are investing in R&D to meet the needs of people suffering from Colorectal Cancer.

Competitive Landscape

The Romania Colorectal Cancer Industry is characterized by the presence of multinational pharmaceutical companies, that leverage their R&D capabilities and introduce innovations in the treatment of oncological diseases. They are working to establish their roots in the country by forming strategic partnerships with local distributors and conducting clinical trials.

Below is a list of leading players operating in the Romania Colorectal Cancer Market:

1. Roche (F. Hoffmann-La Roche Ltd)

Roche is a dominant force in Romania, providing advanced targeted therapies that enable personalized treatment for colorectal cancer patients.

2. Merck KGaA

Merck maintains a strong oncology presence in Romania, specializing in monoclonal antibodies targeting the epidermal growth factor receptor for colorectal cancer.

3. Bristol Myers Squibb (BMS)

BMS is a key player focusing on immuno-oncology, offering checkpoint inhibitors that have revolutionized the treatment of metastatic colorectal cancer.

4. Eli Lilly and Company

Eli Lilly provides essential anti-angiogenic therapies used as second-line treatments to improve survival outcomes for patients with advanced colorectal malignancies.

5. Terapia S.A. (A Sun Pharma Company)

Terapia is the largest local producer, offering a wide range of high-quality generic cytostatic drugs that ensure affordable access to chemotherapy.

6. Amgen Inc.

Amgen contributes to the market through its specialized portfolio of fully human monoclonal antibodies used in the targeted treatment of metastatic colorectal cancer.

7. Sanofi

Sanofi remains a significant provider of cytotoxic agents and aflibercept, integrated into standard chemotherapy regimens for metastatic disease.

8. Bayer AG

Bayer is a major player in the late-line treatment space, producing multi-kinase inhibitors that provide additional therapeutic options.

9. Servier

Servier is highly specialized in oncology, providing oral chemotherapy combinations that serve as a critical option for the management of metastatic colorectal cancer.

10. Antibiotice S.A.

Antibiotice S.A. provides essential generic medications and anti-infectives used in the supportive care and management of complications for oncology patients.